Summary
"An introductory finance textbook for the healthcare industry We are living amid a golden age of biomedical innovation, yet entrepreneurs still struggle with the so-called "Valley of Death" when seeking funding for their biotech start-ups. In Healthcare Finance, Andrew Lo and Shomesh Chaudhuri show that there are better ways to finance breakthrough therapies, and they provide the essential financial tools and concepts for creating the next generation of healthcare technologies.Geared toward MBA and life sciences students, as well as biopharma executives and healthcare investment professionals, this textbook covers the theory and application of financial techniques such as portfolio theory, discounted cash flow analysis, real options, Monte Carlo simulation, and securitization, all within the context of managing biomedical assets. The book demonstrates that more efficient funding structures can reduce financial risks, lower the cost of capital, and bring more lifesaving therapies to patients faster. Students will gain the background, framework, and techniques needed to reshape the healthcare industry in positive ways. Finance doesn't have to be a zero-sum game, and Healthcare Finance proves that it is possible to do well by doing good.Explores new financing methods for the biopharma industryAccessible explanations for making good business decisions in the life sciencesReal-world examples, case studies, and practical applicationsOnline content includes videos of lectures and recitations, interactive widgets, and self-graded problem sets"-- Provided by publisher.
Other formats
Online version: Lo, Andrew W. (Andrew Wen-Chuan) Healthcare finance Princeton, New Jersey : Princeton University Press, [2022]
Contents
Why healthcare finance?
From the laboratory to the patient
Present value relations
Evaluating business opportunities
Valuing bonds
Valuing stocks
Portfolio management and the cost of capital
Therapeutic development and clinical trials
Decision trees and real options
Monte Carlo simulation
Healthcare analytics
Biotech venture capital
Securitizing biomedical assets
Pricing, value, and ethics
Epilogue : a case study pf royalty pharma.